Hos patienter med en anamnese med sukrase insufficiens, isomaltase insufficiens, fruktose intolerans, glukose malabsorption, galaktose malabsorption, galaktose intolerans (f. eks. galaktosæmi) eller Lap laktase mangel bør der foretages en omhyggelig vurdering af fordele og ulemper, før sirolimus tabletter ordineres.
In those patients with a history of sucrase insufficiency, isomaltase insufficiency, fructose intolerance, glucose malabsorption, galactose malabsorption, galactose intolerance (e. g., galactosemia), or Lapp lactase deficiency, a careful risk/ benefit assessment should be performed prior to prescribing sirolimus tablets.